Figure 1From: Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial Overview of the SARAH trial design. ECOG, Eastern Cooperative Oncology Group; RE, radioembolisation.Back to article page